1. |
- Yalcinkaya, Ahmet, et al.
(författare)
-
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
- 2024
-
Ingår i: NPJ VACCINES. - : Springer Nature. - 2059-0105. ; 9:1
-
Tidskriftsartikel (refereegranskat)abstract
- Type I interferons act as gatekeepers against viral infection, and autoantibodies that neutralize these signaling molecules have been associated with COVID-19 severity and adverse reactions to the live-attenuated yellow fever vaccine. On this background, we sought to examine whether autoantibodies against type I interferons were associated with adverse events following COVID-19 vaccination. Our nationwide analysis suggests that type I interferon autoantibodies were not associated with adverse events after mRNA or viral-vector COVID-19 vaccines.
|
|